Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenrong Guben Huanshao Pills is a traditional Chinese medicine (TCM) compound preparation developed and manufactured by Lanzhou Foci Pharmaceutical Co., Ltd. Formulated as an oral pill (teapill), it is derived from ancient classical prescriptions and is clinically indicated for the treatment of conditions associated with kidney deficiency syndrome, such as chronic kidney injury, neurasthenia, and osteoporosis. The preparation is designed to nourish the kidneys, invigorate yang, and strengthen muscles and bones. Modern pharmacological studies indicate that the formulation may exert antioxidant, anti-inflammatory, and neuroprotective effects, potentially through the regulation of neurotransmitters.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenrong Guben Huanshao Pills.